Stock·NASDAQ·Industrials
Verisk Analytics, Inc. (VRSK)
- Market cap
- $24.60B
- P/E
- 28.84
- Dividend yield
- 1.04%
- Street target
- $228.00median of 19 analysts
- 52-week range
- $155.94 $235.89
VRSK stock forecast today
Where VRSK stands today, and what CleaRank Financial AI makes of it.
VRSK at a glance
Verisk Analytics, Inc. (VRSK): Buy, 62/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($181.09 and $186.85).
- Earnings VRSK beat estimates in 6 of the 6 reports in our data, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $19.8M and bought $1.0M over the last 18 months.
- Valuation P/E of 28.8 against 34.0 for the Industrials sector: broadly in line with peers (-15%).
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Verisk Analytics, Inc. (VRSK) Buy, with a model score of 62/100.
The analysts' outlook lifts the score most: 11 of 19 analysts rate it a buy and the median target is 21.5% above the price. Revenue growth holds it back most: revenue grew 4.40%, 7.3 percentage points slower than the sector median. The trend is up: VRSK trades 3.67% above its 50-day average of $181.09 and 0.47% above its 200-day average of $186.85. Over the past year the price fell 19.66%.
Only on CleaRank
Figures we compute ourselves from VRSK's own price, earnings and insider-filing history. Tap one to see it in context.
VRSK stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $187.73 is 3.7% above the 50-day simple moving average of $181.09.Price above its 200-day average ›
The price is 0.5% above the 200-day simple moving average of $186.85.50-day average above the 200-day ›
The 50-day average ($181.09) is 3.1% below the 200-day average ($186.85), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 40% of its 52-week range, between $155.94 and $235.89.
VRSK share price
Pick a period: each tab shows how far VRSK has moved over it, to the last close.
Today's trading
Where VRSK sits inside today's range and its 52-week range.
VRSK fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 28.84 is 15.2% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 7.84 is 96.1% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $885.5M on revenue of $3.1B, a net margin of 28.2%.Beat estimates in most recent reports ›
VRSK beat the EPS estimate in 6 of the 6 reports in our data.Pays a dividend ›
The trailing dividend yield is 1.04%, or $1.95 a share a year.
Key statistics
The headline figures for VRSK.
As of October 27, 2026, VRSK trades at $187.73, with a market value of $24.60B, a P/E ratio of 28.84 and a dividend yield of 1.04%.
What the numbers say
CleaRank Financial AI's reading of VRSK's valuation, growth and risks.
VRSK's trailing P/E of 28.84 sits 15.2% below the 34.0 median for Industrials stocks, which makes it broadly in line with peers.
With revenue growth of 4.40%, VRSK is 7.3 percentage points slower than the sector median of 11.7%. The business converts sales into profit at a net margin of 28.24% and an operating margin of 45.11%. Shareholders' capital earns 293.19%, above the sector median of 17.8%, measured as return on equity. The balance sheet and payout round out the picture, with a trailing dividend yield of 1.04% ($1.95 a share a year).
Verisk Analytics, Inc. (VRSK) reported EPS of $1.82 against the $1.61 analysts had expected, a beat of 13.04% in the February 18, 2026 report. Even so, the stock fell 0.10% in the next session.
Of the 3 reports before the latest, the largest reaction came after the October 29, 2025 report, which beat the estimate by 1.18% while the stock rose 4.62%. The consensus EPS estimate stands at $7.71 for this fiscal year and $8.70 for next, growth of 7.6% for the current year.
VRSK's average daily move is 2.19%, and its beta against the S&P 500 is 0.69. The price is 20.42% below its 52-week high of $235.89.
VRSK against the Industrials sector
How VRSK compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-15% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 15, 2025, VRSK has lost 38.9% against a gain of 18.1% for XLI.
Performance against XLI
VRSK and the Industrials sector fund over the same days.
Revenue and earnings
How much VRSK sells, and how much of it becomes profit.
Revenue growth: Revenue grew 6.6% in FY2025 to $3.1B, from $2.9B a year earlier.
Profit margin: The net margin was 29.6% in FY2025, down from 33.2% the year before.
Profitable: VRSK earned $908M in FY2025.
Earnings reality check
Did VRSK beat what analysts expected, and how did the stock react?
Earnings record: VRSK beat the analyst estimate in 6 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Apr 29, 2026after close | $1.74 | $1.82 | +4.60% | -1.97% | -9.17% |
| Feb 18, 2026after close | $1.61 | $1.82 | +13.04% | -0.10% | +6.38% |
| Oct 29, 2025after close | $1.70 | $1.72 | +1.18% | +4.62% | +2.91% |
| Jul 30, 2025after close | $1.77 | $1.88 | +6.21% | +1.18% | -3.81% |
| May 7, 2025after close | $1.68 | $1.73 | +2.98% | -0.66% | -2.78% |
| Feb 26, 2025after close | $1.60 | $1.61 | +0.63% | +0.72% | +3.08% |
Reports after April 29, 2026 are not yet in our data.
As of October 27, 2026, VRSK has beaten the analyst EPS estimate in 6 of the 6 reports in our data and fell in the first trading session after 3 of those beats; its most recent report in our data, on April 29, 2026, came in 4.60% above the estimate and the stock moved -1.97% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
VRSK AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 54.1, in neutral territory.RSI above 50 ›
An RSI of 54.1 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of VRSK
The score, the reasoning behind it, and what could move the price next.
VRSK is in an uptrend. The price of $187.73 sits 0.47% above its 200-day average of $186.85 and 3.67% above its 50-day average of $181.09. Both averages trail the price, and the 50-day is 3.08% below the 200-day. The price is at 40% of its 52-week range of $155.94 to $235.89, and 20.42% below the high.
Recent gains sit against a weaker longer record: the price rose 10.94% over the past month, fell 11.56% over the past three months and fell 19.66% over the past year. The 14-day RSI of 54.1 is in the neutral zone, and the MACD line is positive.
Rating reaffirmed ›
BMO Capital kept its Outperform rating on October 13, 2026.
Source: Analyst action, BMO Capital, October 13, 2026
- The two levels to watch are the 52-week high at $235.89, which sits above the price, and the 200-day SMA at $186.85, which sits below it.
- The 14-day RSI reads 54.1, in the neutral zone, with the MACD line positive; readings above 70 or below 30 mark stretched momentum.
VRSK's uptrend depends on the price holding above its 50-day average of $181.09 and its 200-day average of $186.85. A close below the 200-day average would be the first sign of that trend weakening. If the price pulls back, the 200-day SMA at $186.85 is the first level it would reach.
VRSK's next level overhead is the 52-week high at $235.89. The 14-day RSI reads 54.1, inside the neutral band of 40 to 60.
Technical indicators
Momentum and trend for VRSK, from its daily closes.
As of October 27, 2026, with VRSK at $187.73, its 14-day RSI is 54.1 (neutral territory), its 50-day simple moving average is $181.09 and its 200-day is $186.85.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What VRSK moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, VRSK's 1-year correlation of daily returns is +0.06 with S&P 500 (SPY), -0.06 with Nasdaq 100 (QQQ), +0.01 with Bitcoin (BTC) and -0.12 with gold (XAU).
VRSK price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
11 of 19 analysts rate it a buy or strong buy, 8 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $228.00 is 21.5% above the price.More buy ratings than three months ago ›
11 of 19 rate it a buy now, against 10 of 19 three months ago.
VRSK Wall Street View
12-month price targets
The price, $187.73, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 13, 2026 | BMO Capital | Maintains | Outperform |
| Oct 13, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Sep 8, 2026 | Barclays | Maintains | Overweight |
| Jul 30, 2026 | UBS | Maintains | Neutral |
| Jul 30, 2026 | Evercore ISI Group | Maintains | In-Line |
| Jul 30, 2026 | Wells Fargo | Maintains | Overweight |
As of October 27, 2026, 19 Wall Street analysts cover VRSK: 11 rate it a buy or strong buy, 8 a hold and 0 a sell or strong sell. Their 12-month price targets range from $195.00 to $260.00. The median VRSK price target is $228.00, 21.5% above the price of $187.73.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
VRSK trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
VRSK trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from VRSK's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much VRSK tends to move, against the market and on its own.
VRSK price history and drawdowns
VRSK's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 2.19% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 47.7%, from June 2025 to October 2026; the price is still 40.1% below that peak.Most 1-year holds ended higher ›
77% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $25,463, against $42,015 in the S&P 500 (SPY).
VRSK Drawdowns & Recovery
As of October 27, 2026, VRSK's worst peak-to-trough fall over the last 10 years with dividends reinvested was -47.7% (June 2025 to October 2026); it is still 40.1% below that peak, and 77% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into VRSK in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: VRSK trailed the S&P 500 over this period: $25,463 against $42,015.
A $10,000 investment in VRSK in October 2016 would be worth about $25,463 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to VRSK, and which have not.
Strongest month, November: an average of +5.66%, up in 9 of 10 years.
Weakest month, December: an average of -2.15%, up in 3 of 10 years.
This month, October: has averaged -1.72%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, VRSK's strongest calendar month has been November (average +5.66%, up in 9 of 10 years) and its weakest December (average -2.15%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
VRSK stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in VRSK, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in VRSK today could grow to about $13,339 by 2030 in the base case, with a 90th-percentile outcome near $25,328 and a 10th-percentile outcome around $7,025. The simulation models price only; at today's 1.04% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
VRSK Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $250 for VRSK by 2030 in the base case, from $188 today (1.3x over 4 years). The 10th-percentile path ends near $132. These are outcomes of a Monte Carlo simulation run on VRSK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $146 | $202 | $278 | |
| 2028 | $138 | $217 | $341 | |
| 2029 | $134 | $233 | $406 | |
| 2030 | $132 | $250 | $475 |
Method: a lognormal simulation of VRSK's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
VRSK insider trading
What the people running the company have bought and sold.
VRSK insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $1.0M on the open market and sold $19.8M.
As of October 27, 2026, VRSK insiders reported 33 open-market sales worth $19.8M and 7 open-market purchases worth $1.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Samuel G. Liss
Director
|
Grant | 156 | - |
| Sep 15, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $74.0K |
| Sep 1, 2026 | Lee M Shavel
Chief Executive Officer
|
Sell | 3.5K | $683.8K |
| Sep 1, 2026 | Lee M Shavel
Chief Executive Officer
|
Option | 3.5K | $367.6K |
| Aug 17, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $72.0K |
| Aug 3, 2026 | Lee M Shavel
Chief Executive Officer
|
Sell | 3.5K | $696.2K |
| Aug 3, 2026 | Lee M Shavel
Chief Executive Officer
|
Option | 3.5K | $367.6K |
| Jul 31, 2026 | Kathy Card Beckles
Officer
|
Sell | 2.0K | $394.9K |
| Jul 29, 2026 | Lee M Shavel
Chief Executive Officer
|
Sell | 2.5K | $550.0K |
| Jul 15, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $76.8K |
| Jun 30, 2026 | Gregory S. Hendrick
Director
|
Grant | 146 | - |
| Jun 30, 2026 | Samuel G. Liss
Director
|
Grant | 167 | - |
| Jun 30, 2026 | Pradip Patiath
Director
|
Grant | 69 | - |
| Jun 30, 2026 | Christopher John Perry
Director
|
Grant | 146 | - |
| Jun 30, 2026 | Sabra R Purtill
Director
|
Grant | 163 | - |
| Jun 15, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $71.8K |
| Jun 5, 2026 | Samuel G. Liss
Director
|
Sell | 4.7K | $851.1K |
| Jun 5, 2026 | Samuel G. Liss
Director
|
Option | 4.7K | $378.0K |
| Jun 2, 2026 | Samuel G. Liss
Director
|
Sell | 6.8K | $1.2M |
| Jun 2, 2026 | Samuel G. Liss
Director
|
Option | 6.8K | $547.5K |
| Jun 1, 2026 | Bruce Edward Hansen
Director
|
Sell | 2.3K | $408.8K |
| Jun 1, 2026 | Bruce Edward Hansen
Director
|
Option | 2.3K | $189.1K |
| May 22, 2026 | Bruce Edward Hansen
Director
|
Sell | 2.3K | $400.5K |
| May 22, 2026 | Bruce Edward Hansen
Director
|
Option | 2.3K | $189.0K |
| May 19, 2026 | Jeffrey J Dailey
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Bruce Edward Hansen
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Gregory S. Hendrick
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Samuel G. Liss
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Pradip Patiath
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Christopher John Perry
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Sabra R Purtill
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Olumide Soroye
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Kimberly S. Stevenson
Director
|
Grant | 1.3K | - |
| May 19, 2026 | Therese Michele Vaughan
Director
|
Grant | 1.3K | - |
| May 15, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $63.7K |
| Apr 15, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $68.6K |
| Mar 31, 2026 | Gregory S. Hendrick
Director
|
Grant | 138 | - |
| Mar 31, 2026 | Samuel G. Liss
Director
|
Grant | 158 | - |
| Mar 31, 2026 | Christopher John Perry
Director
|
Grant | 138 | - |
| Mar 31, 2026 | Sabra R Purtill
Director
|
Grant | 138 | - |
| Mar 17, 2026 | Elizabeth Mann
Chief Financial Officer
|
Sell | 400 | $81.9K |
| Feb 20, 2026 | Gregory S. Hendrick
Director
|
Buy | 500 | $90.1K |
| Feb 20, 2026 | Christopher John Perry
Director
|
Buy | 1.0K | $180.0K |
| Feb 20, 2026 | Kimberly S. Stevenson
Director
|
Buy | 1.0K | $179.2K |
| Jan 15, 2026 | Kathy Card Beckles
Officer
|
Grant | 7.4K | - |
| Jan 15, 2026 | Sunita Bhatia-Holzer
Officer
|
Grant | 6.1K | - |
| Jan 15, 2026 | Nicholas Daffan
Chief Technology Officer
|
Grant | 8.7K | - |
| Jan 15, 2026 | David J. Grover
Officer
|
Grant | 1.2K | - |
| Jan 15, 2026 | Elizabeth Mann
Chief Financial Officer
|
Grant | 11.0K | - |
| Jan 15, 2026 | Lee M Shavel
Chief Executive Officer
|
Grant | 40.2K | - |
| Dec 31, 2025 | Gregory S. Hendrick
Director
|
Grant | 70 | - |
| Dec 31, 2025 | Samuel G. Liss
Director
|
Grant | 134 | - |
| Dec 31, 2025 | Christopher John Perry
Director
|
Grant | 117 | - |
| Dec 31, 2025 | Sabra R Purtill
Director
|
Grant | 117 | - |
| Dec 16, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $65.9K |
| Nov 18, 2025 | Lee M Shavel
Chief Executive Officer
|
Sell | 2.2K | $480.8K |
| Nov 17, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $65.1K |
| Oct 31, 2025 | Jeffrey J Dailey
Director
|
Buy | 500 | $108.5K |
| Oct 31, 2025 | Gregory S. Hendrick
Director
|
Buy | 500 | $108.1K |
| Oct 31, 2025 | Sabra R Purtill
Director
|
Buy | 450 | $98.1K |
| Oct 15, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $72.7K |
| Sep 30, 2025 | Samuel G. Liss
Director
|
Grant | 119 | - |
| Sep 30, 2025 | Christopher John Perry
Director
|
Grant | 104 | - |
| Sep 16, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $76.4K |
| Sep 3, 2025 | Nicholas Daffan
Chief Technology Officer
|
Sell | 5.4K | $1.4M |
| Sep 3, 2025 | Nicholas Daffan
Chief Technology Officer
|
Option | 4.6K | $488.6K |
| Aug 18, 2025 | Lee M Shavel
Chief Executive Officer
|
Sell | 2.2K | $589.6K |
| Aug 15, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $80.4K |
| Aug 13, 2025 | Christopher John Perry
Director
|
Buy | 1.0K | $259.8K |
| Aug 4, 2025 | Nicholas Daffan
Chief Technology Officer
|
Sell | 5.4K | $1.5M |
| Aug 4, 2025 | Nicholas Daffan
Chief Technology Officer
|
Option | 4.6K | $488.6K |
| Aug 1, 2025 | Lee M Shavel
Chief Executive Officer
|
Grant | 1.8K | - |
| Jul 15, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $91.2K |
| Jul 3, 2025 | Nicholas Daffan
Chief Technology Officer
|
Sell | 5.4K | $1.6M |
| Jul 3, 2025 | Kathy Card Beckles
Officer
|
Sell | 326 | $98.1K |
| Jul 3, 2025 | Nicholas Daffan
Chief Technology Officer
|
Option | 4.6K | $488.5K |
| Jun 30, 2025 | Gregory S. Hendrick
Director
|
Grant | 51 | - |
| Jun 30, 2025 | Samuel G. Liss
Director
|
Grant | 96 | - |
| Jun 30, 2025 | Christopher John Perry
Director
|
Grant | 38 | - |
| Jun 30, 2025 | Sabra R Purtill
Director
|
Grant | 38 | - |
| Jun 17, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $92.7K |
| Jun 13, 2025 | Samuel G. Liss
Director
|
Sell | 11.7K | $3.6M |
| Jun 13, 2025 | Samuel G. Liss
Director
|
Option | 11.7K | $850.3K |
| Jun 5, 2025 | Lee M Shavel
Chief Executive Officer
|
Grant | 44.7K | - |
| Jun 4, 2025 | Nicholas Daffan
Chief Technology Officer
|
Sell | 5.4K | $1.7M |
| Jun 4, 2025 | Nicholas Daffan
Chief Technology Officer
|
Option | 4.6K | $488.5K |
| May 20, 2025 | Jeffrey J Dailey
Director
|
Grant | 735 | - |
| May 20, 2025 | Bruce Edward Hansen
Director
|
Grant | 735 | - |
| May 20, 2025 | Gregory S. Hendrick
Director
|
Grant | 735 | - |
| May 20, 2025 | Kathleen Applegate Hogenson
Director
|
Grant | 735 | - |
| May 20, 2025 | Samuel G. Liss
Director
|
Grant | 735 | - |
| May 20, 2025 | Christopher John Perry
Director
|
Grant | 735 | - |
| May 20, 2025 | Sabra R Purtill
Director
|
Grant | 735 | - |
| May 20, 2025 | Olumide Soroye
Director
|
Grant | 735 | - |
| May 20, 2025 | Kimberly S. Stevenson
Director
|
Grant | 735 | - |
| May 20, 2025 | Therese Michele Vaughan
Director
|
Grant | 735 | - |
| May 16, 2025 | Lee M Shavel
Chief Executive Officer
|
Sell | 2.2K | $671.1K |
| May 15, 2025 | Elizabeth Mann
Chief Financial Officer
|
Sell | 300 | $90.7K |
| May 9, 2025 | David J. Grover
Officer
|
Sell | 5.7K | $1.8M |
| May 9, 2025 | David J. Grover
Officer
|
Option | 5.7K | $457.5K |
Source: TwelveData, from SEC Form 4 filings
VRSK stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.